Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
0.9400
-0.0440 (-4.47%)
Oct 6, 2025, 4:00 PM EDT - Market closed
Cytosorbents Market Cap
Cytosorbents has a market cap or net worth of $59.00 million as of October 6, 2025. Its market cap has decreased by -23.68% in one year.
Market Cap
59.00M
Enterprise Value
78.33M
1-Year Change
-23.68%
Ranking
Category
Stock Price
$0.94
Market Cap Chart
Since December 31, 2007, Cytosorbents's market cap has increased from $5.50M to $59.00M, an increase of 972.66%. That is a compound annual growth rate of 14.28%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 3, 2025 | 61.80M | 24.10% |
Dec 31, 2024 | 49.80M | 1.01% |
Dec 29, 2023 | 49.30M | -27.07% |
Dec 30, 2022 | 67.60M | -62.90% |
Dec 31, 2021 | 182.20M | -47.05% |
Dec 31, 2020 | 344.10M | 175.72% |
Dec 31, 2019 | 124.80M | -51.19% |
Dec 31, 2018 | 255.70M | 37.10% |
Dec 29, 2017 | 186.50M | 34.37% |
Dec 30, 2016 | 138.80M | -1.77% |
Dec 31, 2015 | 141.30M | -38.99% |
Dec 31, 2014 | 231.60M | 656.86% |
Dec 31, 2013 | 30.60M | 11.27% |
Dec 31, 2012 | 27.50M | -3.17% |
Dec 30, 2011 | 28.40M | 72.12% |
Dec 31, 2010 | 16.50M | 43.48% |
Dec 31, 2009 | 11.50M | 475.00% |
Dec 31, 2008 | 2.00M | -63.64% |
Dec 31, 2007 | 5.50M | - |
Dec 31, 2007 | 5.50M | - |
View and export this data all the way back to 2007. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 753.98B |
Johnson & Johnson | 454.31B |
AbbVie | 413.22B |
UnitedHealth Group | 326.22B |
Novo Nordisk | 264.73B |
AstraZeneca | 264.35B |
Novartis AG | 256.18B |
Abbott Laboratories | 234.25B |